ReviewInternational journal of molecular sciences2021

Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors.

Mariusz DąbrowskiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.